Brief: Axogen Announces Positive Topline Results From Repose

AxoGen

18/01/2024 23:02

Jan 18 (Reuters) - AxoGen Inc:
    * AXOGEN, INC. ANNOUNCES POSITIVE TOPLINE RESULTS FROM
REPOSE, A
PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF AXOGUARD NERVE CAP
    * AXOGEN INC: POST-MARKETING STUDY MET ITS PRIMARY ENDPOINT
FOR
REDUCTION IN PAIN AS MEASURED BY VISUAL ANALOG SCALE (P-VALUE
<0.05)
    * AXOGEN INC - REPOSE MET ITS PRIMARY ENDPOINT

Further company coverage:  AXGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))